{
  "id": 3785,
  "text": "Tumour Biol 19, 505-516 (1998).1810.Callet, N., Cohen-Solal Le Nir, C.C., Berthelot, E.& Pichon, M.F.Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations.Eur J Gynaecol Oncol 19, 50-56 (1998).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Tumour Biol 19, 505-516 (1998).1810.Callet, N., Cohen-Solal Le Nir, C.C., Berthelot, E.& Pichon, M.F.Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations.Eur J Gynaecol Oncol 19, 50-56 (1998).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据相关研究，血清Cyfra 21.1检测对宫颈癌的诊断具有一定的敏感性和特异性。Cyfra 21.1是一种检测细胞角蛋白片段的标志物，其在宫颈癌患者中的水平常常升高。对于宫颈癌患者的诊断研究表明，Cyfra 21.1可以作为一种辅助性的血清标志物，但其诊断敏感性和特异性并非绝对理想，因此不宜单独用于确诊，而需结合其他临床指标、影像学检查和组织学病理分析以提高诊断准确性。\n\n",
  "query": "宫颈癌患者的血清Cyfra 21.1检测在诊断中的敏感性和特异性如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌患者的血清Cyfra 21.1检测在诊断中的敏感性和特异性如何？\n\n<reference text>: Tumour Biol 19, 505-516 (1998).1810.Callet, N., Cohen-Solal Le Nir, C.C., Berthelot, E.& Pichon, M.F.Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations.Eur J Gynaecol Oncol 19, 50-56 (1998).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据相关研究，血清Cyfra 21.1检测对宫颈癌的诊断具有一定的敏感性和特异性。Cyfra 21.1是一种检测细胞角蛋白片段的标志物，其在宫颈癌患者中的水平常常升高。对于宫颈癌患者的诊断研究表明，Cyfra 21.1可以作为一种辅助性的血清标志物，但其诊断敏感性和特异性并非绝对理想，因此不宜单独用于确诊，而需结合其他临床指标、影像学检查和组织学病理分析以提高诊断准确性。\n\n"
}